Home Other Building Blocks 3-Amino(peg4)propionic acid

3-Amino(peg4)propionic acid

CAS No.:
663921-15-1
Catalog Number:
AG0036WI
Molecular Formula:
C11H23NO6
Molecular Weight:
265.3034
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
100mg
98%
In Stock USA
United States
$158
- +
250mg
95%
In Stock USA
United States
$175
- +
1g
95%
In Stock USA
United States
$369
- +
5g
95%
In Stock USA
United States
$1075
- +
Product Description
Catalog Number:
AG0036WI
Chemical Name:
3-Amino(peg4)propionic acid
CAS Number:
663921-15-1
Molecular Formula:
C11H23NO6
Molecular Weight:
265.3034
MDL Number:
MFCD11041129
IUPAC Name:
3-[2-[2-[2-(2-aminoethoxy)ethoxy]ethoxy]ethoxy]propanoic acid
InChI:
InChI=1S/C11H23NO6/c12-2-4-16-6-8-18-10-9-17-7-5-15-3-1-11(13)14/h1-10,12H2,(H,13,14)
InChI Key:
DKUZHSDZSMQOGQ-UHFFFAOYSA-N
SMILES:
NCCOCCOCCOCCOCCC(=O)O
Properties
Complexity:
190  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
265.153g/mol
Formal Charge:
0
Heavy Atom Count:
18  
Hydrogen Bond Acceptor Count:
7  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
265.306g/mol
Monoisotopic Mass:
265.153g/mol
Rotatable Bond Count:
14  
Topological Polar Surface Area:
100A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-4.1  
Literature
Title Journal
99mTc-labeled cyclic RGD peptides for noninvasive monitoring of tumor integrin αVβ3 expression. Molecular imaging 20111001
Evaluation of 99mTc-labeled cyclic RGD peptide with a PEG4 linker for thrombosis imaging: comparison with DMP444. Bioconjugate chemistry 20110817
Radiolabeled Cyclic RGD Peptides as Radiotracers for Imaging Tumors and Thrombosis by SPECT. Theranostics 20110101
Evaluation of In-Labeled Cyclic RGD Peptides: Effects of Peptide and Linker Multiplicity on Their Tumor Uptake, Excretion Kinetics and Metabolic Stability. Theranostics 20110101
Antibody-maytansinoid conjugates designed to bypass multidrug resistance. Cancer research 20100315
Optical imaging of integrin alphavbeta3 expression with near-infrared fluorescent RGD dimer with tetra(ethylene glycol) linkers. Molecular imaging 20100201
2-Mercaptoacetylglycylglycyl (MAG2) as a bifunctional chelator for 99mTc-labeling of cyclic RGD dimers: effect of technetium chelate on tumor uptake and pharmacokinetics. Bioconjugate chemistry 20090819
Noninvasive imaging of tumor integrin expression using (18)F-labeled RGD dimer peptide with PEG (4) linkers. European journal of nuclear medicine and molecular imaging 20090801
(68)Ga-labeled cyclic RGD dimers with Gly3 and PEG4 linkers: promising agents for tumor integrin alphavbeta3 PET imaging. European journal of nuclear medicine and molecular imaging 20090601
Improving tumor uptake and pharmacokinetics of (64)Cu-labeled cyclic RGD peptide dimers with Gly(3) and PEG(4) linkers. Bioconjugate chemistry 20090401
Improving tumor-targeting capability and pharmacokinetics of (99m)Tc-labeled cyclic RGD dimers with PEG(4) linkers. Molecular pharmaceutics 20090101
DOTA-PESIN, a DOTA-conjugated bombesin derivative designed for the imaging and targeted radionuclide treatment of bombesin receptor-positive tumours. European journal of nuclear medicine and molecular imaging 20070801
Influence of different spacers on the biological profile of a DOTA-somatostatin analogue. Bioconjugate chemistry 20070101
Impact of PKM linkers on biodistribution characteristics of the 99mTc-labeled cyclic RGDfK dimer. Bioconjugate chemistry 20060101
Properties